Apotex Bags First Biosimilar Neulasta, Plans To Undercut Amgen In Canada By 25%

 
• By Ian Schofield
  
Approved
Apotex has received approval in Canada for its biosimilar pegfilgrastim

More from Biosimilars

More from Products